1. A PHASE 2B STUDY OF SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). (12th June 2019) Authors: Kalakonda, N.; Cavallo, F.; Follows, G.; Goy, A.; Vermaat, J.; Casasnovas, O.; Lavee, O.; Maerevoet, M.; Zijlstra, J.; Bakshi, S.; Bouabdallah, R.; Choquet, S.; Gurion, R.; Hill, B.; Jaeger, U.; Sancho, J.; Schuster, M.; Thieblemont, C.; De la Cruz, F.; Egyed, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB2087: EFFICACY OF A 3RD COVID VACCINE, INCLUDING DURING A BTKI PAUSE, IN INDIVIDUALS WITH WALDENSTRÖM MACROGLOBULINEMIA AND FOLLICULAR LYMPHOMA. (23rd June 2022) Authors: Rankin, K.; Beaton, B.; Sasson, S.; Raedemaecker, J.; Wong, A.; Hastak, P.; Phetsouphanh, C.; Warden, A.; Patel, M.; Klemm, V.; Munier, C. M. L.; Carey Hoppe, A.; Tea, F.; Pillay, A.; Ospina, A.; Aggarwal, A.; Lavee, O.; Caterson, I. D.; Turville, S.; Kelleher, A. D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1958 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗